The structure and production of blood platelets

Platelets in Hematologic and Cardiovascular Disorders: A Clinical Handbook

Volumn , Issue , 2007, Pages 1-20

  Italiano, Joseph E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953273471     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545276.003     Document Type: Chapter

References (154)

1. Nachmias VT, Yoshida K. The cytoskeleton of the blood platelet: a dynamic structure. AdvMol Cell Biol 1988;2:181-211.
2. Zucker-Franklin D. The ultrastructure of megakaryocytes and platelets. In Gordon AS (ed). Regulation of hematopoiesis. New York: Appleton-Century-Crofts. 1970:1553-86.
3. Flaumenhaft R.Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol 2003;23:1152-60.
4. Jones OP. Origin of megakaryocyte granules from Golgi vesicles. Anat Rec 1960;138:105-14.
5. de Larouziere V, Brouland JP, Souni F, Drouet L, Cramer E. Inverse immunostaining pattern for synthesized versus endocytosed alpha-granule proteins in human bone marrow megakaryocytes. Br J Haematol 1998;101:618-25.
6. Coller BS, Seligsohn U, West SM, Scudder LE, Norton KJ. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIa and alpha v beta 3 integrins in platelet protein trafficking. Blood 1991;78:2603-10.
7. Handagama P, Bainton DF, Jacques Y, Conn MT, Lazajus RA, Shuman M. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules. J Clin Invest 1993;91:193-200.
8. Handagama P, Scarborough RM, Shuman MA, Bainton DF. Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa). Blood 1993;82:135-8.
9. Diacovo TG, Roth SJ, Buccola JM, et al. Neutrophil rolling, arrest and transmigration across activated, surfaceadherent platelets via sequential action of P-selectin and β2-integrin CD11b/CD18. Blood 1996;88:146-57.
10. Folkman J, Browder T, Palmblad J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 2001;86:22-33.
11. Heijnen HF, Debili N, Vainchencker W, Breton-Gorius J, Geuze HJ, Sixma JJ.Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 1998;91:2313-25.
12. Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science 2006;312:104-7.
13. Emiliani C, Martino S, Orlacchio A, Vezza R, Nenci GG, Gresele P. Platelet glycohydrolase activities: characterization and release. Cell Biochem Funct 1995;13:31-9.
14. Daimon T, Gotoh Y. Cytochemical evidence of the origin of the dense tubular system in the mouse platelet. Histochemistry 1982;76:189-96.
15. Gerrard JM, White JG, Rao GH, Townsend D. Localization of platelet prostaglandin production in the platelet dense tubular system. AmJ Pathol 1976;101: 283-98.
16. White JG. Effects of colchicine and vinca alkyloids on human platelets. AmJ Pathol 1968;53:281-91.
17. White JG, KrivitW. An ultrastructural basis for the shape changes induced in platelets by chilling. Blood 1967;30:625-35.
18. Schwer HD, Lecine P, Tiwari S, Italiano JE Jr, Hartwig JH, Shivdasani RA. A lineage-restricted and divergent β-tubulin isoformis essential for the biogenesis, structure and function of blood platelets. Curr Biol 2001;11: 579-86.
19. Italiano JE, Bergmeier W, Tiwari S, et al.Mechanisms and implications of platelet discoid shape. Blood 2003;15:4789-96.
20. Freson K, De Vos R, Wittevrongel C, et al. The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure. Blood 2005;106:2356-62.
21. Kenney D, Linck R. The cytoskeleton of unstimulated blood platelets: structure and composition of the isolated marginal microtubular band. J Cell Sci 1985;78: 1-22.
22. Hartwig J, DeSisto M. The cytoskeleton of the resting human blood platelet: structure of the membrane skeleton and its attachment to actin filaments. J Cell Biol 1991;112:407-25.
23. Safer D, Nachmias V. Beta thymosins as actin binding peptides. BioEssays 1994;16:473-9.
24. Rosenberg S, Stracher A. Effect of actin-binding protein on the sedimentation properties of actin. J Cell Biol 1982;94:51-5.
25. Rosenberg S, Stracher A, Lucas R. Isolation and characterization of actin and actin-binding protein from human platelets. J Cell Biol 1981;91:201-11.
26. Rosenberg S, Stracher A, Burridge K. Isolation and characterization of a calcium-sensitive α-actinin-like protein from human platelet cytoskeletons. J Biol Chem 1981;256:12986-91.
27. Fucini P, Renner C, Herberhold C, et al. The repeating segments of the F-actin cross-linking gelation factor (ABP-120) have an immunoglobulin-like fold. Nat Struct Biol 1997;4:223-30.
28. Gorlin J, Yamin R, Egan S, et al. Human endothelial actin-binding protein (ABP-280, non-muscle filamin): a molecular leaf spring. J Cell Biol 1990;111:1089-105.
29. Gorlin J, Henske E, Warren S, et al. Actin-binding protein (ABP-280) filamin gene (FLN) maps telomeric to the colar vision locus (R/GCP) and centromeric to G6PD in Xq28. Genomics 1993;17:496-8.
30. Takafuta T, Wu G, Murphy G, et al. Human beta-filamin is a new protein that interacts with the cytoplasmic tail of glycoprotein Ibalpha. J Biol Chem 1998;273:17531-8.
31. Stossel T, Condeelis J, Cooley L, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev 2001;2:138-45.
32. Ohta Y, Suzuki N, Nakamura S, et al. The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 1999;96:2122-8.
33. Meyer S, Zuerbig S, Cunninghan C, et al. Identification of the region in actin-binding protein that binds to the cytoplasmic domain of glycoprotein Ibα. J Biol Chem 1997;272:2914-19.
34. Kovacsovics T, Hartwig J. Thrombin-induced GPIb-IX centralization on the platelet surface requires actin assembly and myosin II activation. Blood 1996;87: 618-29.
35. Fox J, Reynolds, C, Morrow J, et al. Spectrin is associated with membrane-bound actin filaments in platelets and is hydrolyzed by the Ca2+-dependent protease during platelet activation. Blood 1987;69:537-45.
36. Fox J, Boyles J, Berndt M, et al. Identification of a membrane skeleton in platelets. J Cell Biol 1988;106:1525-38.
37. Barkalow K, Italiano J, Chou D, Matsuoka Y, Bennett V, Hartwig JH. α-Adducin dissociates from F-actin and spectrin during platelet activation. J Cell Biol 2003;161:557-70.
38. Kuhlman P, Hughes C, Bennett V. A new function for adducin. Calcium/calmodulin-regulated capping of the barbed ends of actin filaments. J Cell Biol 1996;271:7986-91.
39. Matsuoka Y, Li X, Bennett V. Adducin: structure, function, and regulation. CellMot Life Sci 2000;57:884-95.
40. Kaiser H, O'Keefe E, Bennet V. Adducin: Ca++-dependent association with sites of cell-cell contact. J Cell Biol 1989;109:557-69.
41. Golde D. The stem cell. Sci Am1991;265:86-93.
42. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993;81:2844-53.
43. Ikuta K, Weissman I. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci USA 1992;89: 1502-6.
44. Li Cl, Johnson GR.Murine hematopoietic stem and progenitor cells. I. Enrichment and biological characterization. Blood 1995;85:1472-9.
45. Weissman LL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments and transdifferentiations. Annu Rev Cell Dev Biol 2001;17: 387-403.
46. Akashi, K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000;404:193-7.
47. Adolfsson J, Mansson R, Buza-Vidas N, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential: a revised road map for adult blood lineage commitment. Cell 2005;121:295-306.
48. Debili N, Coulombel L, Croisille L. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow. Blood 1996;88:1284-96.
49. Hunt P. A bipotential megakaryocyte/erythrocyte progenitor cell: the link between erythropoiesis and megakaryopoiesis becomes stronger. J Lab ClinMed 1995;125:303-4.
50. McDonald T, Sullivan P.Megakaryocytic and erythrocytic cell lines share a common precursor cell. Exp Hematol 1993;21:1316-20.
51. Nakeff A, Daniels-McQueen S. In vitro colony assay for a new class of megakaryocyte precursor: colony-forming unit megakaryocyte (CFU-M). Proc Soc Exp BiolMed 1976; 151:587-90.
52. Levin J.Murine megakaryocytopoiesis in vitro: an analysis of culture systems used for the study of megakaryocyte colony-forming cells and of the characteristics of megakaryocyte colonies. Blood 1983;61:617-23.
53. Long M, Gragowski L, Heffner C. Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte. J Clin Invest 1985;76:431-8.
54. Williams N, Eger R, Jackson H. Two-factor requirement for murine megakaryocyte colony formation. J Cell Physiol 1982;110:101-4.
55. Lev-Lehman E, Deutsh V, Eldor A, Soreq H. Immature human megakaryocytes produce nuclear associated acetylcholinesterase. Blood 1997;89:3644-53.
56. Breton-Gorius J, Guichard J. Ultrastructural localization of peroxidase activity in human platelets and megakaryocytes. AmJ Pathol 1972;66:227-93.
57. Jackson C. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 1973;42:413-21.
58. Briddell R, Brandt J, Stravena J, Srour E, Hoffman R. Characterization of the human burst-forming unit-megakaryocyte. Blood 1989;74:145-51.
59. Long M, Williams N, Ebbe S. Immature megakaryocytes in the mouse: physical charatceristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor. Blood 1982;59:569-75.
60. Odell T, Jackson CJ, Reiter R. Generation cycle of rat megakaryocytes. Exp Cell Res 1968;53:321.
61. Ebbe S, Stohlman F.Megakaryocytopoiesis in the rat. Blood 1965;26:20-34.
62. Ebbe S. Biology of megakaryocytes. Prog Hemost Thromb 1976;3:211-29.
63. Therman E, Sarto G, Stubblefiels P. Endomitosis: a reappraisal. Hum Genet 1983;63:13-18.
64. Odell T, Jackson C, Friday T.Megakaryocytopoiesis in rats with special reference to polyploidy. Blood 1970;35: 775-82.
65. Raslova H, Roy L, Vourch C, et al.Megakaryocyte polyploidization is associated with a functional gene amplification. Blood 2003;101:541-4.
66. Nagata Y, Muro Y, Todokoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol 1997;139:449-57.
67. Vitrat N, Cohen-Solal K, Pique C, et al. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood 1998;91:3711-23.
68. Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: the megakaryocyte example. J Cell Physiol 2002;190:7-20.
69. Wang Z, Zhang Y, Kamen D, et al. Cyclin D3 is essential for megakaryocytopoiesis. Blood 1995;86:3783-8.
70. Gu XF, Allain A, Li L, et al. Expression of cyclin B in megakaryocytes and cells of other hematopoietic lineages. C R Acad Sci III 1993;316:1438-45.
71. Hayles J, Fisher D, Woodlard A. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc22-mitotic B cyclin complex. Cell 1994;78:813-22.
72. Broek D, Bartlett R, Crawford K. Involvement of p34cdc2 in establishing the dependency of S phase on mitosis. Nature 1991;349:388-93.
73. Zhang Y, Wang Z, Ravid K. The cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinase. J Biol Chem 1996;271: 4266-72.
74. Datta NS, Williams JL, Caldwell J, Curry AM, Ashcraft EK, LongMW. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content.Mol Biol Cell 1996;7:209-23.
75. Kozar K.Mouse development and cell proliferation in the absence of d-cyclins. Cell 2004;118:477-91.
76. Gengy Y. Cyclin E ablation in the mouse. Cell 2003;114: 431-43.
77. Zhang Y, Nagata Y, Yu G, et al. Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression. Blood 2004;103:3717-26.
78. Kautz J, DeMarsh QB. Electron microscopy of sectioned blood and bone marrow elements. Rev Hematol 1955;10:314-323;discussion, 324-44.
79. Yamada F. The fine structure of the megakaryocyte in the mouse spleen. Acta Anat 1957;29:267-90.
80. Behnke O. An electron microscope study of megakaryocytes of rat bone marrow. I. The development of the demarcation membrane system and the platelet surface coat. J Ultrastruct Res 1968;24:412-28.
81. Bentfield-Barker ME, Bainton D. Ultrastructure of rat megakaryocytes after prolonged thrombocytopenia. J Ultrastruct Res 1977;61:201-14.
82. Zucker-Franklin D. In Greaves MF, Grossi CE, Marmot AM, Zucker-Franklin D (eds). Atlas of Blood Cells, Function, and Pathology. Vol. 2. Philadelphia: Lea & Febiger, 1988.
83. Nakao K, Angrist A.Membrane surface specialization of blood platelet and megakaryocyte. Nature 1968;217: 960-1.
84. Zucker-Franklin D, Benson K, Myers K. Absence of a surface-connected canalicular system in bovine platelets. Blood 1985;65:241-4.
85. Shaklai M, Tavassoli M. Demarcation membrane system in rat megakaryocyte and the mechanism of platelet formation: A membrane reorganization process. J Ultrastruct Res 1978;62:270-85.
86. Kosaki G. In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets? Int J Hematol 2005;81:208-19.
87. Radley J, HatshormM.Megakaryocyte fragments and the microtubule coil. Blood Cells 1987;12:603-8.
88. Radley JM, Haller CJ. The demarcation membrane system of the megakaryocyte: a misnomer? Blood 1982;60: 213-19.
89. Becker RP, De Bruyn PP. The transmural passage of blood cells into myeloid sinusoids and the entry of platelets into the sinusoidal circulation; a scanning electron microscopic investigation. Am J Anat 1976;145:1046-52.
90. Wright J. The origin and nature of blood platelets. Boston Med Surg J 1906;154:643-5.
91. Thiery JB, Bessis M. Platelet genesis from megakaryocytes observed in live cells. C R. Acad Sci Paris 1956;242:290.
92. Behnke O. An electron microscope study of the rat megakaryocyte. II. Some aspects of platelet release and microtubules. J Ultrastruct Res 1969;26:111-29.
93. Choi ES, Nichol JL, Hokom MM, Homkohl AC, Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995;85:402-13.
94. Cramer EM, Norol F, Guichard J, et al. Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand. Blood 1997;89:2336-46.
95. Leven RM.Megakaryocyte motility and platelet formation. ScanningMicrosc 1997;1:1701-9.
96. Tablin F, Castro M, Leven RM. Blood platelet formation in vitro: the role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci 1990;97:59-70.
97. Handagama PJ, Feldman BF, Jain NC, Farver TB, Kono C. In vitro platelet release by rat megakaryocytes: effect of metabolic inhibitors and cytoskeletal disrupting agents. Am J Vet Res 1987;48:1142-6.
98. Miyazaki H, Inoue H, Yanagida M, et al. Purification of rat megakaryocyte colony-forming cells using monoclonal antibody against rat platelet glycoprotein IIb/IIIa. Exp Hematol 1992;20:855-61.
99. Choi E. Regulation of proplatelet and platelet formation in vitro. In Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D (eds). Thrombopoeisis and Thrombopoietins:Molecular, Cellular, Preclinical, and Clinical Biology. Totowa, NJ: Humana Press, 1997:271-84.
100. Lichtman MA, Chamberlain JK, Simon W, Santillo PA. Parasinusoidal location of megakaryocytes in marrow: a determinant of platelet release. AmJ Hematol 1978;4:303-12.
101. Scurfield G, Radley JM. Aspects of platelet formation and release. AmJ Hematol 1981;10:285-96.
102. Tavassoli M, Aoki M. Localization of megakaryocytes in the bone marrow. Blood Cells 1989;15:3-14.
103. Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995;81:695-704.
104. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 1997;16: 3965-73.
105. Lecine P, Villeval J, Vyas P, Swencki B, Yuhui X, Shivdasani R.Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood 1998;92:1608-16.
106. Italiano JEJ, Lecine P, Shivdasani RA, Hartwig JH. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol 1999;147:1299-12.
107. Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005;115:3348-54.
108. Patel SR, Richardson J, Schulze H, et al. Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytes. Blood 2005;106:4076-85.
109. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969;48:963-74.
110. Kaufman R, Airo R, Pollack S. Origin of pulmonary megakaryocytes. Blood 1965;25:767-75.
111. Trowbridge EA, Martin JF, Slater DN, Kishk YT, Warren CW, Harley PJ, Woodcock B. The origin of platelet count and volume. Clin Phys PhysiolMeas 1984;5:145-56.
112. Rojnuckarin P, Kaushansky K. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase c alpha. Blood 2001;97: 154-61.
113. Kelley MJ, Jawien W, Ortel TL, Korczak JF.Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000;26:106-8.
114. Kunishima S, Kojima T, Matsushita T, et al.Mutations in the NMMHC-a gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Haegglin anomaly/Sebastian syndrome). Blood 2001;97:1147-9.
115. Richardson J, Shivdasani R, Boers C, Hartwig J, Italiano J Jr. Mechanisms of organelle transport and capture along proplatelets during platelet production. Blood 2005;115:4066-75.
116. Radley JM. Ultastructural aspects of platelet formation. Prog Clin Biol Res 1986;215:387-98.
117. Radley JM, Scurfield G. The mechanism of platelet release. Blood 1980;56:996-9.
118. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of hsc differentiation and mobilization. Physiology (Bethesda) 2005;20:349-56.
119. Avecilla ST, Hattori K, Heissig B, et al. Chemokinemediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004;10:64-71.
120. Avraham H, Banu N, Scadden DT, Abraham J, Groopman JE.Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 1994;83:2126-32.
121. Avraham H, Cowley S, Chi SY, Jiang S, Groopman JE. Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J Clin Invest 1993;91:2378-2384.
122. Behnke O, Forer A. From megakaryocytes to platelets: platelet morphogenesis takes place in the bloodstream. Eur J Haematol Suppl 1998;60:3-23.
123. Cramer L.Molecular mechanism of actin-dependent retrograde flow in lamellipodia of motile cells. Frontiers Biosci 1997;2:260-70.
124. Scheinin T, Koivuneimi A.Megakaryocytes in the pulmonary circulation. Blood 1963;22:82-7.
125. Kinosita R, Ohno S. Biodynamics of thrombopoiesis. In Johnson S, Rebuck J, Horn R (eds). Blood Platelets. Boston: Little, Brown, 1958.
126. Tavassoli M, Aoki M.Migration of entire megakaryocytes through the marrow-blood barrier. Br J Haematol 1981;48:25-9.
127. Hamada T, Mohle R, Hesselgesser J, et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J ExpMed 1998;188:539-48.
128. Riviere C, Subra F, Cohen-Solal K, Cordette-Lagarde V, Letestu R, Auclair C. Phenotypic and functional evidence for the expression of CXCR receptor during megakaryocytopoiesis. Blood 1999;93:1511-23.
129. Kowalska MA, Ratajczak J, Hoxie J, et al.Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: determination of response to stromal-derived factor-1 by megakaryocytes and platelets. Br J Haematol 1999;104:220-9.
130. Levine RF, Eldor A, Shoff PK, Kirwin S, Tenza D, Cramer EM. Circulating megakaryocytes. Delivery of large numbers of intact, mature megakaryocytes to the lungs. Eur J Haematol 1993;51:233-46.
131. Kaushansky K. Thrombopoietin: a tool for understanding thrombopoiesis. J Thromb Hematol 2003;1:1587-92.
132. Segal G, Stueve T, Adamson J. Analysis of murine megakaryocyte ploidy and size: effects of interleukin-3. J Cell Physiol 1988;137:537-44.
133. Yang Y, Ciarletta A, Temple P. Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986;47:3-10.
134. Kaushansky K. Lineage-specific hematopoietic growth factors.NEngl J Med 2006;354:2034-5.
135. Ito T, Ishida Y, Kashiwagi R, Kuriya S. Recombinant human c-Mpl ligand is not a direct stimulator of proplatelet formation of human megakaryocytes. Br J Haematol 1996;94:387-90.
136. Gordge MP.Megakaryocyte apoptosis: sorting out the signals. Br J Pharmacol 2005;145:271-3.
137. Radley JM, Haller, CJ. Fate of senescent megakaryocytes in the bone marrow. Br J Haematol 1983;53:277-87.
138. Kaluzhny Y, Ravid K. Role of apoptotic processes in platelet biogenesis. Acta Haematol 2004;111:67-77.
139. de Botton S, Sabri S, Daugas E, et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 2002;100:1310-17.
140. Sanz C, Benet I, Richard C, et al. Antiapoptotic protein Bcl-x(L) is up-regulated during megakaryocytic differentiation of CD34(+) progenitors but is absent from senescent megakaryocytes. Exp Hematol 2001;29: 728-35.
141. Battinelli E, Loscalzo J. Nitric oxide induces apoptosis in megakaryocytic cell lines. Blood 2000;95:3451-9.
142. Battinelli E, Willoughby SR, Foxall T, Valeri CR, Loscalzo J. Induction of platelet formation from megakaryocytoid cells by nitric oxide. Proc Natl Acad Sci USA 2001;98:14458-63.
143. Kim JA, Jung YJ, Seoh JY, Woo SY, Seo JS, Kim HL. Gene expression profile of megakaryocytes from human cord blood CD34(+) cells ex vivo expanded by thrombopoietin. Stem Cells 2002;20:402-16.
144. Clarke MC, Savill J, Jones DB, Noble BS, Brown SB. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Biol Chem 2003;160:577-87.
145. Brown SB, Clarke MC, Magowan L, Sanderson H, Savill J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J Biol Chem 2000;275:5987-96.
146. Kerrigan SW, Gaur M, Murphy RP, Shattil SJ, Leavitt AD. Caspase-12: a developmental link between G-proteincoupled receptors and integrin alphaIIb-beta3 activation. Blood 2004;104:1327-34.
147. Carlsson L, Markey F, Blikstad I, et al. Reorganization of actin in platelets stimulated by thrombin as measured by the DNAse I inhibition assay. Proc Natl Acad Sci USA 1979;76:6376-80.
148. Karlsson R, Lassing I, Hoglund AS, et al. The organization of microfilaments in spreading platelets: a comparison with fibroblasts and glial cells. J Cell Physiol 1984;121:96-113.
149. Nachmias VT, Kavaler J, Jacubowitz S. Reversible association of myosin with the platelet cytoskeleton. Nature 1985;313:70-2.
150. Davies T, Drotts D, Weil GJ, et al. Cytoplasmic calcium is necessary for thrombin-induced platelet activation. J Biol Chem 1989;264:19600-6.
151. Brass LF. Ca2+ homeostasis in unstimulated platelets. J Biol Chem 1984;259:12563-70.
152. Brass LF, Joseph SA. A role for inositol triphosphate in intracellular Ca2+ mobilization and granule secretion in platelets. J Biol Chem 1985;260:15172-9.
153. Yin HL, Stossel TP. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature 1979;281:583-6.
154. Fox JE, Phillips DR. Inhibition of actin polymerization in blood platelets by cytochalasins. Nature 1981;292:650-2.